New Head for The Ritchie Centre

By Rob Clancy, staff writer

Professor Suzanne Miller, scientific leader in fetal and neonatal neurodevelopment, has been appointed as the new Head of The Ritchie Centre.

Professor Suzanne Miller Heads up The Ritchie Centre at Hudson Institute of Medical Research
Professor Suzanne Miller

Hudson Institute’s Director and CEO, Professor Elizabeth Hartland, and the Acting Head of the School of Clinical Sciences, Professor Peter Ebeling, jointly made the announcement on Friday, 1 July.

Outstanding scientific leader

Prof Hartland described Prof Miller as an outstanding national and international scientific leader in fetal and neonatal neurodevelopment, who will provide strong and inspirational leadership and advocacy for The Ritchie Centre.

Prof Miller takes over as Head from Professor Stuart Hooper, who has led The Ritchie Centre through a wonderful period of evolution over many years and who intends to continue his outstanding research there.

Leading The Ritchie Centre in women’s, infant and child health

Prof Miller is a fetal physiologist, and as Research Group Head, Neurodevelopment and Neuroprotection, has developed a comprehensive program of perinatal brain research, with established models of the principal causes of newborn brain injury – fetal growth restriction, intrauterine inflammation, preterm birth and birth asphyxia.

Prof Miller is a NHMRC Senior Research Fellow, and her many awards include prestigious grants and fellowships from the Cerebral Palsy Alliance, the Bill and Melinda Gates Foundation and the Australian Research Council.

READ MORE | Prof Miller’s work on Preventing brain injury in babies

Contact us

Hudson Institute communications
t: + 61 3 8572 2761

About Hudson Institute

Hudson Institute’ s research programs deliver in five areas of medical need – inflammation, cancer, reproductive health, newborn health, and hormones and health. More

Hudson News

Get the inside view on discoveries and patient stories

“Thank you Hudson Institute researchers. Your work brings such hope to all women with ovarian cancer knowing that potentially women in the future won't have to go through what we have!”

Alana Chantry